Arthur Fratamico
CIK 1598129 · Chief Business Officer · last filed 2023-03-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$107
Companies
4
Total Filings
13
Lifetime Open-Market Net
$78.3K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PBLA | Director | 9,615 | $0.01 | $107 | $0 | 3 | 2023-03-29 |
| Galera Therapeutics, Inc. (GRTX) Delisted | Chief Business Officer | — | $0.14 | — | $0 | 2 | 2021-01-28 |
| Panbela Therapeutics, Inc. (SNBP) Delisted | Director | 2,424 | — | — | $0 | 1 | 2020-09-01 |
| Vitae Pharmaceuticals, Inc (VTAE) Delisted | Chief Business Officer | 0 | — | — | $78.3K | 5 | 2016-10-25 |
Recent Filings · Page 2 of 2
13 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-02-16 | Vitae Pharmaceuticals, Inc (VTAE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-08-31 | Vitae Pharmaceuticals, Inc (VTAE) Delisted | Buy (P) | +10,000 | $78.3K | EDGAR |
| 2015-02-18 | Vitae Pharmaceuticals, Inc (VTAE) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–13 of 13
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.